[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100525476":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":40,"locations":46,"responsibleParty":104,"collaborators":106,"id":114,"slug":115,"hasResults":116,"nctId":117,"briefTitle":118,"officialTitle":118,"acronym":18,"eligibilityCriteria":119,"healthyVolunteers":116,"sex":120,"minAge":121,"maxAge":18,"enrollmentInfo":122,"targetDuration":18,"studyType":125,"phases":126,"briefSummary":128,"conditions":129,"keywords":132,"overallStatus":49,"whyStopped":18,"lastUpdateSubmitDate":135,"lastUpdatePostDateStruct":136,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":144},{"fullName":5,"class":6},"University of Sydney","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"REBUILD-SM Group","EXPERIMENTAL","Participants randomised to the intervention will receive the self-management package, including the REBUILD app. Structured self-management support via telephone or Zoom call will be provided 4 times during the 12-week intervention period.",[13],"Behavioral: Pulmonary Fibrosis self-management package and smartphone application",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard Care Group","NO_INTERVENTION","In the control arm, participants will receive standard care and a reduced capability version of the REBUILD app to be used for data-capture only. They will also receive phone\u002FZoom calls at the same frequency during the 12-week intervention period, but no health advice will be given. After 26 weeks, participants in this group will receive access to the fully functional REBUILD app, however they will not receive the self-management content or the support phone calls provided to the intervention group.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","Pulmonary Fibrosis self-management package and smartphone application","The pulmonary fibrosis package includes modules on understanding treatment options for pulmonary fibrosis, managing medication and side effects, understanding and accessing clinical trials, managing shortness of breath, managing fatigue and mood, managing co-existing conditions, the role and importance of pulmonary rehabilitation and regular physical activity, role of oxygen therapy, smoking cessation advice and support, accessing community support, and communicating with others when living with pulmonary fibrosis.\n\nThe RE-BUILD app is used as a tool for data collection and to help participants self-monitor their disease over time. Participants enter their health data, including baseline conditions, medications and diagnosis, pulmonary function results and supplementary oxygen use. It also tracks air quality data close to the participant as well as physical activity level (step count). The app also has links to ILD-related educational resources.",[9],[26],"REBUILD-SM",[28,31,34,37],{"name":29,"affiliation":5,"role":30},"Tamera Corte","PRINCIPAL_INVESTIGATOR",{"name":32,"affiliation":33,"role":30},"Dan Chambers","The University of Queensland",{"name":35,"affiliation":36,"role":30},"Nicole Goh","Institute of Breathing and Sleep",{"name":38,"affiliation":39,"role":30},"Ian Glaspole","The Alfred",[41],{"name":42,"role":43,"phone":44,"phoneExt":18,"email":45},"Carly Barton","CONTACT","+61 2 9515 5682","Carly.Barton@Sydney.edu.au",[47,63,78,93],{"facility":48,"status":49,"city":50,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"Royal Prince Alfred Hospital","RECRUITING","Sydney","New South Wales","2050","Australia","AU",{"type":56,"coordinates":57},"Point",[58,59],151.20732,-33.86785,{"lat":59,"lon":58},[62],{"name":42,"role":43,"phone":44,"phoneExt":18,"email":45},{"facility":64,"status":49,"city":65,"state":66,"zip":67,"country":53,"countryCode":54,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"The Prince Charles Hospital","Brisbane","Queensland","4032",{"type":56,"coordinates":69},[70,71],153.02809,-27.46794,{"lat":71,"lon":70},[74],{"name":75,"role":43,"phone":76,"phoneExt":18,"email":77},"Sjane Timmins","+61 7 3139 6298","Sjane.Timmins@health.qld.gov.au",{"facility":79,"status":49,"city":80,"state":81,"zip":82,"country":53,"countryCode":54,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Alfred Hospital","Melbourne","Victoria","3004",{"type":56,"coordinates":84},[85,86],144.96332,-37.814,{"lat":86,"lon":85},[89],{"name":90,"role":43,"phone":91,"phoneExt":18,"email":92},"Karen Symons","+61 3 9076 3600","K.Symons@Alfred.org.au",{"facility":94,"status":49,"city":80,"state":81,"zip":95,"country":53,"countryCode":54,"cosmosGeoPoint":96,"geoPoint":98,"contacts":99},"Austin Health","3084",{"type":56,"coordinates":97},[85,86],{"lat":86,"lon":85},[100],{"name":101,"role":43,"phone":102,"phoneExt":18,"email":103},"Lisa Fuhrmeister","+61 3 9496 3874","Lisa.Fuhrmeister@austin.org.au",{"type":105,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[107,109,112],{"name":108,"class":6},"Monash University",{"name":110,"class":111},"Lung Foundation Australia","UNKNOWN",{"name":113,"class":6},"University of Tasmania","100525476","a-randomised-clinical-trial-of-a-digital-self-management-package-for-people-with-interstitial-lung-disease-100525476",false,"NCT06122233","A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease","Inclusion Criteria:\n\n* Diagnosis of fibrotic ILD\n* In possession of a smartphone\u002Ftablet and an email address\n* Able to understand written and spoken English\n* Adequate digital literacy to complete requirements of trial\n* On stable ILD treatment for 30 days prior to enrolment\n\nExclusion Criteria:\n\n* Not in possession of a smartphone\u002Ftablet\n* Insufficient digital literacy to complete requirements of trial\n* Unable to communicate in written\u002Fspoken English\n* Not on stable ILD treatment for 30 days prior to enrolment\n* Acute exacerbation within 30 days prior to enrolment\n* Participating in pulmonary rehab at enrolment or during 12-week intervention period\n* Unable to provide informed consent","ALL","18 Years",{"count":123,"type":124},400,"ESTIMATED","INTERVENTIONAL",[127],"NA","The goal of this clinical trial is to compare REBUILD-SM (a purpose-built smartphone app and self-management package) with standard care in people with interstitial lung disease (ILD). The main question it aims to answer is:\n\n• Does REBUILD-SM improve health-related quality of life, symptoms, anxiety, self-efficacy and physical activity for people with ILD?\n\nParticipants in the intervention group will work through the self-management package with support from a healthcare professional via phone or Zoom. They will also enter deidentified health data into the RE-BUILD smartphone app to track their progress over time. Participants in the control group will use a reduced functionality version of the smartphone app only.\n\nResearchers will compare both groups to see if there is any difference in health-related quality of life, symptoms, anxiety, self-efficacy and level of physical activity.",[130,131],"Lung Diseases, Interstitial","Pulmonary Fibrosis",[133,134],"Self-Management","Chronic diseases","2025-04-01",{"date":137,"type":138},"2025-04-04","ACTUAL",{"date":140,"type":138},"2024-06-03",{"date":142,"type":124},"2027-08",{"name":5,"class":6},4]